While discounted playing cards will help reduce the stress of substantial drug expenditures during the short term, they do not handle the systemic concerns driving up prescription prices in the U.S. Broader plan modifications could tackle the basis causes of rising drug rates, for example deficiency of transparency in pricing plus the part of inter